Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRA · BSE: 540788 · Healthcare · 10 announcements

Share price
₹130.02
Market cap
₹133.8 Cr
Revenue (annual)
₹24.98 Cr
Net profit (annual)
₹0.05 Cr
P/E (TTM)
-295.7×Sector 57.8×
Promoter holding
46.58%+28.19% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:02 IST BSE
Promoter Buying

Aspira Pathlab & Diagnostics Promoter Buying: ₹0.01 Cr

Promoter Jay Arvind Bhanushali acquired 1,387 equity shares of Aspira Pathlab & Diagnostics Ltd through market purchase, increasing their stake from 7.25% to 7.27%.

Value
₹0.01 Cr
Promoter stake change
+0.02%
18:11 IST BSE
Promoter Buying

Aspira Pathlab & Diagnostics Promoter Buying

Promoter Jay Arvind Bhanushali acquired 1,387 shares of Aspira Pathlab & Diagnostics Ltd via an open-market transaction, increasing his stake by 0.02%.

Promoter stake change
+0.02%
11:00 IST BSE
Promoter Buying

Aspira Pathlab & Diagnostics Promoter Buying: ₹0 Cr

Promoter Jay Arvind Bhanushali acquired 74 shares of Aspira Pathlab & Diagnostics Ltd via market purchase on September 10, 2026.

Value
₹0.00 Cr
13:36 IST BSE
Promoter Buying

Aspira Pathlab & Diagnostics Promoter Buying: ₹0.01 Cr

Promoter Jay Arvind Bhanushali acquired 957 shares of Aspira Pathlab & Diagnostics Ltd via market purchase for ₹0.01 Crore.

Value
₹0.01 Cr
Promoter stake change
+0.01%
11:52 IST BSE
Promoter Buying

Aspira Pathlab & Diagnostics Promoter Buying

Jay Arvind Bhanushali (Promoter) acquired 623 equity shares of Aspira Pathlab & Diagnostics Ltd via open market, increasing his holding slightly.